HI
LEGN icon

Handelsinvest Investeringsforvaltning’s Legend Biotech LEGN Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$248K Sell
4,415
-2,292
-34% -$138K 0.12% 218
2023
Q4 		$404K Buy
+6,707
New +$425K 0.16% 180

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's LEGN Position: Q1 2024 in Review

Handelsinvest Investeringsforvaltning reduced its Legend Biotech (LEGN) stake by 34% in Q1 2024, selling an estimated $138K and leaving 4,415 shares worth $248K. The position accounts for 0.12% of the portfolio, ranked #218.

Handelsinvest Investeringsforvaltning first reported a position in LEGN in Q4 2023 and has held it in 2 quarters since. The position peaked at $404K in Q4 2023. 192 funds tracked by Wall St. Rank hold LEGN as of Q1 2024.

  • Handelsinvest Investeringsforvaltning held 4,415 shares of Legend Biotech worth $248K as of Q1 2024.
  • Handelsinvest Investeringsforvaltning sold 2,292 Legend Biotech shares in Q1 2024, an estimated $138K.
  • Legend Biotech made up 0.12% of Handelsinvest Investeringsforvaltning's portfolio in Q1 2024, its #218 holding.
  • Handelsinvest Investeringsforvaltning first reported a position in Legend Biotech in Q4 2023 and has held it in 2 quarters since.
  • Handelsinvest Investeringsforvaltning's Legend Biotech position peaked at $404K in Q4 2023.
  • 192 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2024.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q1 2024, filed 19 Apr 2024.